Pushkal Garg

Insider Reports History

Location
Watertown, MA
Signature
By: Brett Budzinski, Attorney-in-Fact For: Pushkal Garg
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pushkal Garg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALNYLAM PHARMACEUTICALS, INC. EVP Chief R&D Common Stock 20.2K $9.19M $454.37 03 Oct 2025 Direct
ALNYLAM PHARMACEUTICALS, INC. EVP Chief R&D Restricted Stock Units 1.91K $466K $244.11 27 Feb 2025 Direct
ALNYLAM PHARMACEUTICALS, INC. EVP Chief R&D Common Stock 431 $202K $469.31 01 Oct 2025 by Managed Account
ALNYLAM PHARMACEUTICALS, INC. EVP Chief R&D Common Stock 250 $117K $469.31 01 Oct 2025 by Trust
SQZ Biotechnologies Co Director Stock Option 39.9K 14 Jun 2023 Direct
ALNYLAM PHARMACEUTICALS, INC. EVP Chief R&D Performance Stock Option 2015 (right to buy) 0 27 Jan 2025 Direct
ALNYLAM PHARMACEUTICALS, INC. EVP Chief R&D Stock Option (right to buy) 0 24 Mar 2025 Direct

Insider Reports Filed by Pushkal Garg

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALNY ALNYLAM PHARMACEUTICALS, INC. 01 Oct 2025 19 -$2.69M 4 EVP Chief R&D 03 Oct 2025, 17:12
ALNY ALNYLAM PHARMACEUTICALS, INC. 15 Aug 2025 15 -$1.3M 4 EVP Chief R&D 19 Aug 2025, 17:28
ALNY ALNYLAM PHARMACEUTICALS, INC. 21 Mar 2025 4 -$2.64M 4 CMO & EVP Dev & Med Affairs 25 Mar 2025, 16:10
ALNY ALNYLAM PHARMACEUTICALS, INC. 03 Mar 2025 16 -$621K 4 CMO & EVP Dev & Med Affairs 05 Mar 2025, 16:21
ALNY ALNYLAM PHARMACEUTICALS, INC. 27 Feb 2025 10 -$226K 4 CMO & EVP Dev & Med Affairs 03 Mar 2025, 16:31
ALNY ALNYLAM PHARMACEUTICALS, INC. 13 Feb 2025 19 -$788K 4 CMO & EVP Dev & Med Affairs 18 Feb 2025, 16:47
ALNY ALNYLAM PHARMACEUTICALS, INC. 27 Jan 2025 5 -$10.6M 4 CMO & EVP Dev & Med Affairs 29 Jan 2025, 16:03
ALNY ALNYLAM PHARMACEUTICALS, INC. 12 Dec 2024 7 -$440K 4 CMO & EVP Dev & Med Affairs 13 Dec 2024, 16:13
ALNY ALNYLAM PHARMACEUTICALS, INC. 25 Nov 2024 6 -$422K 4 CMO & EVP Dev & Med Affairs 27 Nov 2024, 17:22
ALNY ALNYLAM PHARMACEUTICALS, INC. 08 Oct 2024 1 $0 4 CMO & EVP Dev & Med Affairs 10 Oct 2024, 16:06
ALNY ALNYLAM PHARMACEUTICALS, INC. 24 Jun 2024 13 -$486K 4 CMO & EVP Dev & Med Affairs 26 Jun 2024, 16:28
ALNY ALNYLAM PHARMACEUTICALS, INC. 01 Mar 2024 2 $0 4 CMO & EVP Dev & Med Affairs 05 Mar 2024, 16:21
ALNY ALNYLAM PHARMACEUTICALS, INC. 27 Feb 2024 7 -$89.1K 4 CMO & EVP Dev & Med Affairs 29 Feb 2024, 16:17
ALNY ALNYLAM PHARMACEUTICALS, INC. 15 Feb 2024 4 -$194K 4 CMO & EVP Dev & Med Affairs 20 Feb 2024, 16:09
ALNY ALNYLAM PHARMACEUTICALS, INC. 03 Aug 2023 11 -$1.41M 4 CMO & EVP Dev & Med Affairs 07 Aug 2023, 18:05
SQZB SQZ Biotechnologies Co 14 Jun 2023 1 $0 4 Director 15 Jun 2023, 16:43
ALNY ALNYLAM PHARMACEUTICALS, INC. 26 Apr 2023 12 -$846K 4 CMO & EVP Dev & Med Affairs 28 Apr 2023, 17:54
ALNY ALNYLAM PHARMACEUTICALS, INC. 03 Mar 2023 5 -$3.13M 4 CMO & EVP Dev & Med Affairs 07 Mar 2023, 15:07
ALNY ALNYLAM PHARMACEUTICALS, INC. 27 Feb 2023 2 $0 4 CMO & EVP Dev & Med Affairs 01 Mar 2023, 15:22
ALNY ALNYLAM PHARMACEUTICALS, INC. 03 Aug 2022 7 -$974K 4 CMO & EVP Dev & Med Affairs 05 Aug 2022, 16:14
SQZB SQZ Biotechnologies Co 15 Jun 2022 1 $0 4 Director 16 Jun 2022, 17:01
ALNY ALNYLAM PHARMACEUTICALS, INC. 23 Feb 2022 1 $0 4 CMO & EVP Dev & Med Affairs 25 Feb 2022, 15:12
ALNY ALNYLAM PHARMACEUTICALS, INC. 31 Dec 2021 0 $0 3 CMO & EVP Dev & Med Affairs 04 Jan 2022, 15:03
SQZB SQZ Biotechnologies Co 15 Jun 2021 1 $0 4 Director 17 Jun 2021, 17:16